CORT Competitors & Alternatives
Compare Corcept Therapeutics Incorporated with similar stocks in the same industry
Biotechnology
CORT
Main Stock$116.28
Tradestie Score
55
Market Cap
$8.88B
P/E Ratio
258.8
Revenue Growth
0.3%
Analyst Upside
+21.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$62.15
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.83
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.90
|
$12.36B | 17.6 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.58
|
$11.09B | 20.3 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.80
|
$10.76B | - | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$245.81
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.21
|
$10.53B | 152.5 | 72 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.27
|
$10.49B | - | 69 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.74
|
$10.22B | - | 70 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$457.96
|
$10.01B | - | 59 | Compare |
More CORT Analysis
Data updated: Oct 21, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry